Geneos Wealth Management’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-250
| Closed | -$4K | – | 2369 |
|
|
2022
Q2 | $4K | Hold |
250
| – | – | ﹤0.01% | 2264 |
|
|
2022
Q1 | $6K | Hold |
250
| – | – | ﹤0.01% | 2278 |
|
|
2021
Q4 | $6K | Hold |
250
| – | – | ﹤0.01% | 2355 |
|
|
2021
Q3 | $7K | Hold |
250
| – | – | ﹤0.01% | 2355 |
|
|
2021
Q2 | $7K | Hold |
250
| – | – | ﹤0.01% | 2340 |
|
|
2021
Q1 | $7K | Hold |
250
| – | – | ﹤0.01% | 2539 |
|
|
2020
Q4 | $7K | Hold |
250
| – | – | ﹤0.01% | 2370 |
|
|
2020
Q3 | $3K | Hold |
250
| – | – | ﹤0.01% | 2325 |
|
|
2020
Q2 | $2K | Hold |
250
| – | – | ﹤0.01% | 2370 |
|
|
2020
Q1 | $3K | Hold |
250
| – | – | ﹤0.01% | 2184 |
|
|
2019
Q4 | $6K | Hold |
250
| – | – | ﹤0.01% | 2146 |
|
|
2019
Q3 | $7K | Hold |
250
| – | – | ﹤0.01% | 2009 |
|
|
2019
Q2 | $6K | Hold |
250
| – | – | ﹤0.01% | 2076 |
|
|
2019
Q1 | $8K | Hold |
250
| – | – | ﹤0.01% | 1910 |
|
|
2018
Q4 | $7K | Sell |
250
-300
| -55% | -$8.4K | ﹤0.01% | 1889 |
|
|
2018
Q3 | $25K | Buy |
550
+300
| +120% | +$13.6K | ﹤0.01% | 1480 |
|
|
2018
Q2 | $9K | Hold |
250
| – | – | ﹤0.01% | 1764 |
|
|
2018
Q1 | $7K | Hold |
250
| – | – | ﹤0.01% | 1771 |
|
|
2017
Q4 | $8K | Buy |
+250
| New | +$8K | ﹤0.01% | 1708 |
|